What Prime Global does

Prime Global is a privately held, PE-backed life science communications agency serving the global bio-pharmaceutical industry. Founded in 1999 and headquartered in Knutsford, UK, with a US regional headquarters in New York, the company operates from 21 locations across the UK, US, EU, and APAC and employs approximately 400 experts, of which 80% hold PhDs, MDs, or PharmDs in scientific and editorial roles. The business is structured around five integrated service lines — Strategic Consultancy and Life-cycle Management, Medical Strategy and Scientific Communications, HEOR/RWE and Market Access, Commercial Launch and Promotional Education, and Patient Engagement and Insights — delivered through a holding structure that includes wholly owned subsidiaries HCD Economics (HEOR, acquired 2022), earthware (communications, acquired 2022), and Aventine (US market access, acquired 2023, operating as Prime Aventine).

The company's platform architecture combines traditional professional-services delivery with Prime Solutions Lab, an in-house innovation hub launched in 2024 that bundles seven proprietary AI-augmented products — Prime Explain (AI systematic literature review), Prime Detail (AI dossier development), Prime Avail (AI publication generation), Prime Simplifai (plain language summaries), Prime PosterSynergy, Prime Acumen (content engagement), and Prime Chatboss (healthcare chatbot manager) — alongside standalone tools such as the DermaPro 3D PASI calculator. Prime generates revenue through bespoke professional-services engagements with pharmaceutical, biotech, and medical device clients across the product lifecycle, sold via an enterprise field-sales motion targeting top-tier pharma accounts including Bristol Myers Squibb, Pfizer, and medac Pharma. Pricing is not publicly disclosed and operates on a contact-based engagement model typical of B2B professional services. The company has been owned by Levine Leichtman Capital Partners since April 2021 and has pursued an active roll-up strategy, executing four acquisitions since 2020 to broaden capabilities and geographic reach.

Name

Prime Global

Legal name

Prime Global Medical Communications Ltd.

Website

https://primeglobalpeople.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

Prime Global is a private, PE-backed life science communications agency serving global bio-pharmaceutical companies with integrated medical communications, HEOR, market access, and patient engagement services, supported by 400 experts across 21 locations and a proprietary AI product suite.

Ownership category

akta.pro rank

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Strategic Consultancy Services: Professional services revenue generated from strategic consultancy engagements with pharmaceutical and biotech clients across the product lifecycle
2. Medical Communications Services: Scientific communications, publications, medical education and strategic planning services for life sciences industry
3. HEOR and Market Access Services: Health economics, real-world evidence, and market access consultancy including systematic reviews, value dossiers, and economic modeling
4. Patient Engagement Services: Patient advocacy engagement, education programs and clinical trial support services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Prime Global is a healthcare communications and consulting firm that delivers medical communications, health economics and outcomes research (HEOR), market access, scientific publications, and patient engagement services for bio-pharmaceutical and medical device companies. The firm combines scientific expertise with a proprietary AI-enabled product suite developed through its in-house innovation function.

Product overview

Prime Global is a life science communications agency operating as a platform of integrated services spanning strategic consultancy, medical strategy and publications, HEOR/RWE/market access, commercial launch, and patient engagement. At the core of its differentiated offering is Prime Solutions Lab — a dynamic hub combining creative, scientific, digital, and AI expertise. Within the Lab, Prime has developed a suite of proprietary AI-powered products: Prime Explain (systematic literature reviews), Prime Detail (dossier development), Prime Avail (publication generation), Prime Simplifai (plain language summaries), Prime PosterSynergy (poster optimization), Prime Acumen (content engagement), and Prime Chatboss (healthcare chatbot manager). Supporting these are standalone products such as DermaPro, an award-winning 3D PASI calculator for psoriasis assessment. The integrated approach is designed to guide clients from early development through launch and post-launch across the product lifecycle.

Differentiator

Problem solved

Functional benefit

Brands

• Prime Solutions Lab: Innovation hub integrating science, creativity, data, and technology to deliver impactful solutions for healthcare clients.
• Prime Explain
• Prime Detail
• Prime Avail
• Prime Simplifai
• Prime PosterSynergy
• Prime Acumen
• Prime Chatboss
• DermaPro

Products and services

• Medical communications services End-to-end medical communications support for bio-pharmaceutical companies, including scientific narrative development, congress materials, advisory boards, and stakeholder engagement across the product lifecycle.
• HEOR and market access services Health economics and outcomes research, evidence generation, value communication, and market access support to help bio-pharmaceutical and medical device clients demonstrate product value and secure payer coverage.
• Scientific publications services Support for peer-reviewed publications, congress abstracts, manuscripts, and other scientific content for pharmaceutical and medical device sponsors.
• Patient engagement services Patient-focused communications, advocacy relations, and engagement programs designed for pharmaceutical sponsors seeking to incorporate patient perspectives and outcomes into brand and evidence strategies.
• Medical devices communications services Communications, evidence, and market access support tailored specifically to medical device manufacturers and their distinct regulatory and payer environments.

Quantifiable outcome

• 76-87% of c.13k target HCPs engaged within first 4 months of omnichannel campaign
• +5 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature8 records

Partnerships

Three partnerships are on record, tiered core.

• Bristol Myers SquibbcoreStrategic or Co-development Partner · 1 April 2024Collaborative research partnership with Bristol Myers Squibb to evaluate a proprietary GPT4-powered genAI screening tool for systematic literature reviews. The study investigated concordance between AI and human reviewers for screening 160 publications from a published SLR on PD-L1 diagnostic assays, demonstrating genAI's potential to enhance literature screening efficiency.
• medac PharmacoreStrategic or Co-development Partner · 1 January 2024Collaborative development of DermaPro, an award-winning 3D PASI calculator for psoriasis assessment. This partnership resulted in PM Society Digital Awards 2024 Gold win in HCP Education category.
• Pfizer InccoreStrategic or Co-development Partner · 1 June 2023Collaboration on research assessing the potential of ChatGPT4.0 to generate plain language summaries (PLS) of clinical studies. The study evaluated understandability of AI-generated PLS compared to human-written versions, demonstrating that human-assisted AI can achieve comparable quality.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Fishawack Health: A global medical communications and commercialization agency serving pharmaceutical and biotech clients with publications, medical affairs, HEOR, and creative services. Highly comparable as a mid-size, PE-backed (Bridgepoint) specialist agency competing for the same enterprise pharma clients as Prime Global.
• OPEN Health: A global healthcare communications and evidence group offering medical communications, HEOR, market access, and patient engagement services to biopharma. Directly comparable as a multi-capability, mid-size, PE-backed (Ares) competitor in life sciences communications and evidence.
• AMICULUM: An independent global medical communications agency providing scientific content, publications, and strategic consultancy to pharmaceutical clients. Comparable as a mid-size specialist competitor in medical communications with similar service lines and therapeutic area depth.
• Inizio: A global healthcare commercialization platform combining medical affairs, market access, and communications capabilities (incorporating Fishawack, Ashfield, and other agencies). Comparable as a scaled, PE-backed (EQT) competitor offering the same integrated life sciences services Prime Global provides.
• Real Chemistry: A healthcare marketing and communications agency providing medical affairs, brand communications, and data-driven engagement to biopharma. Comparable as a mid-to-large specialist agency competing for enterprise pharma communications and omnichannel engagement work.

Broad incumbents

• Syneos Health Communications: A clinical and commercial life sciences services organization (now private under Elliott/Veritas/Patient Square) offering medical communications, advertising, and consulting alongside its core CRO operations. Comparable as a larger, broader incumbent with overlapping medical affairs and communications capabilities.
• IQVIA: A global life sciences technology and services leader providing RWE, HEOR, market access, and commercial services to biopharma. Comparable as a broad incumbent with overlapping HEOR, RWE, and consulting capabilities where Prime Global competes for evidence and access work.
• Publicis Health: The healthcare arm of Publicis Groupe offering advertising, medical communications, market access, and consulting to pharma. Comparable as a large, holding-company-backed incumbent that competes for enterprise pharma communications and omnichannel HCP engagement business.
• McCann Health: The global healthcare communications network of IPG (McCann Worldgroup) providing medical communications, advertising, and consulting to pharma and biotech. Comparable as a large, holding-company-backed incumbent with overlapping medical affairs and scientific communications capabilities.
• Havas Life: The global health and wellness communications network of Havas providing medical communications, brand communications, and consulting to pharma. Comparable as a broader network competitor in healthcare and life sciences communications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@primeglobal2751
• LinkedInlinkedin.com/company/2444682/admin/updates
• Instagraminstagram.com/primeglobalbuzz
• Xx.com/primeglobalbuzz

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prime Global